Capital International Investors Regeneron Pharmaceuticals, Inc. Transaction History

Capital International Investors

$504 Billion
Q3 2024

A detailed history of Capital International Investors transactions in Regeneron Pharmaceuticals, Inc. stock. As of the latest transaction made, Capital International Investors holds 3,346,395 shares of REGN stock, worth $2.43 Billion. This represents 0.7% of its overall portfolio holdings.

Number of Shares

3,346,395

Previous 3,134,122 6.77%

Holding current value

$2.43 Billion

Previous $3.29 Billion 6.79%

% of portfolio

0.7%

Previous 0.69%

25 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	BUY	$1024.09 - $1201.76 $217 Million - $255 Million	212,273 Added 6.77%	3,346,395 $3.52 Billion
Q2 2024 Aug 13, 2024	BUY	$883.2 - $1071.19 $4.51 Million - $5.48 Million	5,112 Added 0.16%	3,134,122 $3.29 Billion
Q1 2024 May 14, 2024	BUY	$902.69 - $993.35 $192 Million - $212 Million	213,038 Added 7.31%	3,129,010 $3.01 Billion
Q4 2023 Feb 13, 2024	SELL	$775.18 - $881.7 $45.2 Million - $51.5 Million	-58,366 Reduced 1.96%	2,915,972 $2.56 Billion
Q3 2023 Nov 13, 2023	BUY	$692.45 - $844.37 $12.3 Million - $15 Million	17,723 Added 0.6%	2,974,338 $2.45 Billion
Q2 2023 Aug 11, 2023	BUY	$700.03 - $830.35 $562 Million - $667 Million	803,143 Added 37.3%	2,956,615 $2.12 Billion
Q1 2023 May 15, 2023	BUY	$680.49 - $826.97 $424 Million - $516 Million	623,529 Added 40.76%	2,153,472 $1.77 Billion
Q4 2022 Feb 14, 2023	SELL	$705.89 - $766.39 $167 Million - $182 Million	-237,193 Reduced 13.42%	1,529,943 $1.1 Billion
Q3 2022 Nov 14, 2022	SELL	$573.97 - $724.32 $14.2 Million - $18 Million	-24,799 Reduced 1.38%	1,767,136 $1.22 Billion
Q2 2022 Aug 15, 2022	BUY	$548.35 - $738.84 $59.2 Million - $79.8 Million	108,036 Added 6.42%	1,791,935 $1.06 Billion
Q1 2022 May 16, 2022	BUY	$595.12 - $698.43 $844 Million - $990 Million	1,417,899 Added 533.04%	1,683,899 $1.18 Billion
Q4 2021 Feb 14, 2022	SELL	$543.48 - $670.97 $471 Million - $581 Million	-865,968 Reduced 76.5%	266,000 $168 Million
Q3 2021 Nov 15, 2021	SELL	$574.03 - $680.96 $90.8 Million - $108 Million	-158,178 Reduced 12.26%	1,131,968 $685 Million
Q2 2021 Aug 16, 2021	SELL	$472.8 - $558.54 $7,092 - $8,378	-15 Reduced -0.0%	1,290,146 $721 Million
Q1 2021 May 14, 2021	SELL	$446.73 - $548.2 $33.4 Million - $40.9 Million	-74,665 Reduced 5.47%	1,290,161 $610 Million
Q4 2020 Feb 12, 2021	SELL	$478.3 - $607.98 $37.4 Million - $47.5 Million	-78,158 Reduced 5.42%	1,364,826 $659 Million
Q3 2020 Nov 13, 2020	SELL	$544.75 - $658.21 $69.5 Million - $83.9 Million	-127,490 Reduced 8.12%	1,442,984 $808 Million
Q2 2020 Aug 14, 2020	SELL	$493.32 - $643.92 $25.5 Million - $33.3 Million	-51,741 Reduced 3.19%	1,570,474 $979 Million
Q1 2020 May 15, 2020	BUY	$336.18 - $494.43 $35.2 Million - $51.8 Million	104,782 Added 6.91%	1,622,215 $792 Million
Q4 2019 Feb 18, 2020	BUY	$274.13 - $376.51 $137,887 - $189,384	503 Added 0.03%	1,517,433 $570 Million
Q3 2019 Nov 14, 2019	BUY	$273.46 - $318.39 $5,742 - $6,686	21 Added 0.0%	1,516,930 $421 Million
Q2 2019 Aug 14, 2019	SELL	$299.6 - $414.82 $18.6 Million - $25.8 Million	-62,205 Reduced 3.94%	1,516,909 $475 Million
Q1 2019 May 15, 2019	BUY	$372.08 - $439.57 $18.6 Million - $22 Million	50,002 Added 3.27%	1,579,114 $648 Million
Q4 2018 Feb 14, 2019	SELL	$335.82 - $403.04 $70.9 Million - $85 Million	-211,000 Reduced 12.13%	1,529,112 $571 Million
Q3 2018 Nov 14, 2018	BUY	$351.14 - $408.51 $611 Million - $711 Million	1,740,112 New	1,740,112 $703 Million

Others Institutions Holding REGN

# of Institutions

1,535

Shares Held

83.8M

Call Options Held

1.22M

Put Options Held

1.51M

View Full List

About REGENERON PHARMACEUTICALS, INC.

Ticker REGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 107,190,000
Market Cap $77.7B
Description
Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...

More about REGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Capital International Investors, based on Form 13F filings with the SEC.

News

Stay updated on Capital International Investors with notifications on news.

Account

Capital International Investors Regeneron Pharmaceuticals, Inc. Transaction History